SPRY2 and cancer: miR-21 overexpression is closely associated with cancer cell proliferation, metastasis, and disease prognosis of MM, non-Hodgkin’s lymphoma, leukemia and various other non-hematological solid tumors (14–16) miR-21 may regulate the expression of SPRY2.